“Lebrikizumab Treatment Improves Lichenification and Other Clinical Signs of Atopic Dermatitis in Adults and Adolescents With Moderate-to-Severe AD and Skin of Color”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s625. Accessed May 1, 2026. https://skin.dermsquared.com/skin/article/view/3861.